Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | hydroxysteroid (17-beta) dehydrogenase 10 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | 3-oxoacyl-[acyl-carrier-protein] reductase | hydroxysteroid (17-beta) dehydrogenase 10 | 252 aa | 251 aa | 24.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0069 | 0.004 | 0.012 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0106 | 0.0199 | 0.4467 |
Brugia malayi | glutaminase DH11.1 | 0.0553 | 0.2135 | 0.2135 |
Schistosoma mansoni | hypothetical protein | 0.075 | 0.2986 | 0.4422 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.3349 | 0.4959 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.133 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.0199 | 0.0199 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0163 | 0.0446 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0163 | 0.0446 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0163 | 0.0446 | 0.133 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0742 | 0.2953 | 0.2953 |
Schistosoma mansoni | tar DNA-binding protein | 0.0742 | 0.2953 | 0.4372 |
Brugia malayi | hypothetical protein | 0.0106 | 0.0199 | 0.0199 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.3349 | 1 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0069 | 0.004 | 0.004 |
Schistosoma mansoni | tar DNA-binding protein | 0.0742 | 0.2953 | 0.4372 |
Loa Loa (eye worm) | hypothetical protein | 0.075 | 0.2986 | 0.2986 |
Brugia malayi | RNA binding protein | 0.0742 | 0.2953 | 0.2953 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0069 | 0.004 | 0.0059 |
Loa Loa (eye worm) | hypothetical protein | 0.122 | 0.5022 | 0.5022 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.0446 |
Schistosoma mansoni | hypothetical protein | 0.1619 | 0.6754 | 1 |
Schistosoma mansoni | hypothetical protein | 0.075 | 0.2986 | 0.4422 |
Brugia malayi | hypothetical protein | 0.0068 | 0.0036 | 0.0036 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0065 | 0.002 | 0.002 |
Schistosoma mansoni | tar DNA-binding protein | 0.0742 | 0.2953 | 0.4372 |
Echinococcus multilocularis | GPCR, family 2 | 0.075 | 0.2986 | 0.8916 |
Echinococcus multilocularis | tar DNA binding protein | 0.0742 | 0.2953 | 0.8816 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0163 | 0.0446 | 1 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0163 | 0.0446 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0163 | 0.0446 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.133 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0163 | 0.0446 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.075 | 0.2986 | 0.2986 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.075 | 0.2986 | 0.8916 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0163 | 0.0446 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0742 | 0.2953 | 0.8816 |
Leishmania major | hypothetical protein, conserved | 0.0106 | 0.0199 | 0.392 |
Loa Loa (eye worm) | glutaminase 2 | 0.0553 | 0.2135 | 0.2135 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0163 | 0.0446 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.1619 | 0.6754 | 0.6754 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.075 | 0.2986 | 0.8916 |
Brugia malayi | Isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.0446 |
Brugia malayi | TAR-binding protein | 0.0742 | 0.2953 | 0.2953 |
Schistosoma mansoni | glutaminase | 0.0553 | 0.2135 | 0.3161 |
Brugia malayi | isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.0446 |
Brugia malayi | N-terminal motif family protein | 0.122 | 0.5022 | 0.5022 |
Schistosoma mansoni | hypothetical protein | 0.075 | 0.2986 | 0.4422 |
Loa Loa (eye worm) | RNA binding protein | 0.0742 | 0.2953 | 0.2953 |
Mycobacterium ulcerans | glutaminase | 0.0553 | 0.2135 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2369 | 1 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.133 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.2369 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1619 | 0.6754 | 0.6754 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0163 | 0.0446 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.075 | 0.2986 | 0.2986 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.075 | 0.2986 | 0.8916 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.133 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.075 | 0.2986 | 0.8916 |
Loa Loa (eye worm) | glutaminase | 0.0553 | 0.2135 | 0.2135 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.122 | 0.5022 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0742 | 0.2953 | 0.2953 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.066 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0069 | 0.004 | 0.012 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.2369 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0742 | 0.2953 | 0.2953 |
Schistosoma mansoni | hypothetical protein | 0.075 | 0.2986 | 0.4422 |
Schistosoma mansoni | tar DNA-binding protein | 0.0742 | 0.2953 | 0.4372 |
Schistosoma mansoni | tar DNA-binding protein | 0.0742 | 0.2953 | 0.4372 |
Brugia malayi | Latrophilin receptor protein 2 | 0.075 | 0.2986 | 0.2986 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.3349 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0553 | 0.2135 | 0.5 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0163 | 0.0446 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.075 | 0.2986 | 0.8916 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0163 | 0.0446 | 0.133 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 37.6505 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.